United States (US) Pharmaceutical CDMO Market (2025-2031) | Value, Forecast, Competitive Landscape, Trends, Growth, Segmentation, Outlook, Industry, Companies, Size & Revenue, Analysis, Share

Market Forecast By Application (Infectious Diseases, Oncology, Neurological Disorders), By Workflow (Commercial, Clinical), By Product (Synthesis, Manufacturing, Drug, API) And Competitive Landscape
Product Code: ETC9973350 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Pharmaceutical CDMO Market Outlook
  • Market Size of United States (US) Pharmaceutical CDMO Market, 2024
  • Forecast of United States (US) Pharmaceutical CDMO Market, 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Revenues & Volume for the Period 2021- 2031
  • United States (US) Pharmaceutical CDMO Market Trend Evolution
  • United States (US) Pharmaceutical CDMO Market Drivers and Challenges
  • United States (US) Pharmaceutical CDMO Price Trends
  • United States (US) Pharmaceutical CDMO Porter's Five Forces
  • United States (US) Pharmaceutical CDMO Industry Life Cycle
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Oncology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Neurological Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Workflow for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Commercial for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Clinical for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Synthesis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Manufacturing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By Drug for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Pharmaceutical CDMO Market Revenues & Volume By API for the Period 2021- 2031
  • United States (US) Pharmaceutical CDMO Import Export Trade Statistics
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Workflow
  • Market Opportunity Assessment By Product
  • United States (US) Pharmaceutical CDMO Top Companies Market Share
  • United States (US) Pharmaceutical CDMO Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Pharmaceutical CDMO Company Profiles
  • United States (US) Pharmaceutical CDMO Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Pharmaceutical CDMO Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Pharmaceutical CDMO Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Pharmaceutical CDMO Market - Industry Life Cycle

3.4 United States (US) Pharmaceutical CDMO Market - Porter's Five Forces

3.5 United States (US) Pharmaceutical CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) Pharmaceutical CDMO Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.7 United States (US) Pharmaceutical CDMO Market Revenues & Volume Share, By Product, 2021 & 2031F

4 United States (US) Pharmaceutical CDMO Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Pharmaceutical CDMO Market Trends

6 United States (US) Pharmaceutical CDMO Market, By Types

6.1 United States (US) Pharmaceutical CDMO Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.1.4 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.1.5 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.2 United States (US) Pharmaceutical CDMO Market, By Workflow

6.2.1 Overview and Analysis

6.2.2 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Commercial, 2021- 2031F

6.2.3 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.3 United States (US) Pharmaceutical CDMO Market, By Product

6.3.1 Overview and Analysis

6.3.2 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Synthesis, 2021- 2031F

6.3.3 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Manufacturing, 2021- 2031F

6.3.4 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By Drug, 2021- 2031F

6.3.5 United States (US) Pharmaceutical CDMO Market Revenues & Volume, By API, 2021- 2031F

7 United States (US) Pharmaceutical CDMO Market Import-Export Trade Statistics

7.1 United States (US) Pharmaceutical CDMO Market Export to Major Countries

7.2 United States (US) Pharmaceutical CDMO Market Imports from Major Countries

8 United States (US) Pharmaceutical CDMO Market Key Performance Indicators

9 United States (US) Pharmaceutical CDMO Market - Opportunity Assessment

9.1 United States (US) Pharmaceutical CDMO Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) Pharmaceutical CDMO Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.3 United States (US) Pharmaceutical CDMO Market Opportunity Assessment, By Product, 2021 & 2031F

10 United States (US) Pharmaceutical CDMO Market - Competitive Landscape

10.1 United States (US) Pharmaceutical CDMO Market Revenue Share, By Companies, 2024

10.2 United States (US) Pharmaceutical CDMO Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All